
doi: 10.1007/bf01964237
pmid: 3143572
Haemophilus influenzae has become increasingly resistant to beta-lactam antibiotics. Three major mechanisms, both enzymatic and non-enzymatic, are involved. Enzymatic resistance is mainly due to production of a TEM-1 plasmid-mediated beta-lactamase, and in some cases to a new enzyme ROB-1. Of the non-enzymatic mechanisms, decreased permeability due to alteration of outer membrane proteins seems to be rare in comparison to decreased affinity of penicillin-binding proteins for beta-lactam antibiotics. Enzymatic resistance is present in about 10-20% of clinical isolates, while non-enzymatic resistance is present only in 2-4%.
Cell Membrane Permeability, Drug Resistance, Microbial, Muramoylpentapeptide Carboxypeptidase, beta-Lactams, Haemophilus influenzae, beta-Lactamases, Anti-Bacterial Agents, Bacterial Proteins, Hexosyltransferases, Peptidyl Transferases, Humans, Penicillin-Binding Proteins, Carrier Proteins
Cell Membrane Permeability, Drug Resistance, Microbial, Muramoylpentapeptide Carboxypeptidase, beta-Lactams, Haemophilus influenzae, beta-Lactamases, Anti-Bacterial Agents, Bacterial Proteins, Hexosyltransferases, Peptidyl Transferases, Humans, Penicillin-Binding Proteins, Carrier Proteins
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 24 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
